Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients
Tóm tắt
Antigen specificity and IgG subclass could be significant in the natural history of Chagas' disease. The relationship between the different stages of human Chagas' disease and the profiles of total IgG and its subclasses were thus analysed here; they were directed against a crude T. cruzi extract and three recombinant antigens: the T. cruzi kinetoplastid membrane protein-11 (rKMP-11), an internal fragment of the T. cruzi HSP-70 protein192-433, and the entire Trypanosoma rangeli HSP-70 protein. Seventeen Brazilian acute chagasic patients, 50 Colombian chronic chagasic patients (21 indeterminate and 29 cardiopathic patients) and 30 healthy individuals were included. Total IgG and its subtypes directed against the above-mentioned recombinant antigens were determined by ELISA tests. The T. cruzi KMP-11 and T. rangeli HSP-70 recombinant proteins were able to distinguish both acute from chronic chagasic patients and infected people from healthy individuals. Specific antibodies to T. cruzi crude antigen in acute patients came from IgG3 and IgG4 subclasses whereas IgG1 and IgG3 were the prevalent isotypes in indeterminate and chronic chagasic patients. By contrast, the specific prominent antibodies in all disease stages against T. cruzi KMP-11 and T. rangeli HSP-70 recombinant antigens were the IgG1 subclass.
T. cruzi KMP-11 and the T. rangeli HSP-70 recombinant proteins may be explored together in the immunodiagnosis of Chagas' disease. Polarising the IgG1 subclass of the IgG response to T. cruzi KMP-11 and T. rangeli HSP-70 recombinant proteins could have important biological effects, taking into account that this is a complement fixing antibody.
Tài liệu tham khảo
Goto Y, Carter D, Reed SG: Immunological dominance of Trypanosoma cruzi tandem repeat proteins. Infect Immun. 2008, 76: 3967-3974. 10.1128/IAI.00604-08.
Campo VA, Buscaglia CA, Di Noia JM, Frasch AC: Immunocharacterization of the mucin-type proteins from the intracellular stage of Trypanosoma cruzi. Microbes Infect. 2006, 8: 401-409. 10.1016/j.micinf.2005.07.008.
Cooley G, Etheridge RD, Boehlke C, Bundy B, Weatherly DB, Minning T, Haney M, Postan M, Laucella S, Tarleton RL: High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2008, 2: e316-10.1371/journal.pntd.0000316.
Bhatia V, Garg NJ: Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice. Clin Vaccine Immunol. 2008, 15: 1158-1164. 10.1128/CVI.00144-08.
Rodriguez AM, Santoro F, Afchain D, Bazin H, Capron A: Trypanosoma cruzi infection in B-cell-deficient rats. Infect Immun. 1981, 31: 524-529.
Scott MT: The nature of immunity against Trypanosoma cruzi in mice recovered from acute infection. Parasite Immunol. 1981, 3: 209-218. 10.1111/j.1365-3024.1981.tb00400.x.
World Health Organization: Control of Chagas' disease. WHO Technical Report Series. 2002, 905: 1-120.
Dutra WO, Rocha MO, Teixeira MM: The clinical immunology of human Chagas disease. Trends Parasitol. 2005, 21: 581-587. 10.1016/j.pt.2005.09.007.
Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV: Pathogenesis of chronic Chagas heart disease. Circulation. 2007, 115: 1109-1123. 10.1161/CIRCULATIONAHA.106.624296.
Tarleton RL: Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol. 2007, 19: 430-434. 10.1016/j.coi.2007.06.003.
Kierszenbaum F: Where do we stand on the autoimmunity hypothesis of Chagas disease?. Trends Parasitol. 2005, 21: 513-516. 10.1016/j.pt.2005.08.013.
Umekita L, Ramos D, Barbaro K, Mota I: Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes. Immunol Lett. 1999, 10: 73-76. 10.1016/S0165-2478(99)00139-X.
Umekita LF, Mota I: How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?. Braz J Med Biol Res. 2000, 33: 253-258. 10.1590/S0100-879X2000000300001.
Stebeck CE, Beecroft RP, Singh BN, Jardim A, Olafson RW, Tuckey C, Prenevost KD, Pearson TW: Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites. Mol Biochem Parasitol. 1995, 71: 1-13. 10.1016/0166-6851(95)00022-S.
Thomas MC, García-Pérez JL, Alonso C, López MC: Molecular characterization of KMP11 from Trypanosoma cruzi: a cytoskeleton-associated protein regulated at the translational level. DNA Cell Biol. 2000, 19: 47-57. 10.1089/104454900314708.
Olson CL, Nadeau KC, Sullivan MA, Winquist AG, Donelson JE, Walsh CT, Engman DM: Molecular and biochemical comparison of the 70-kDa heat shock proteins of Trypanosoma cruzi. J Biol Chem. 1994, 269: 3868-3874.
Requena JM, López MC, Jimenez-Ruiz A, de la Torre JC, Alonso C: A head-to-tail tandem organization of hsp70 genes in Trypanosoma cruzi. Nucleic Acids Res. 1988, 16: 1393-1406. 10.1093/nar/16.4.1393.
Requena JM, Jimenez-Ruiz A, Soto M, Assiego R, Santarén JF, Lopez MC, Patarroyo ME, Alonso C: Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol Biochem Parasitol. 1992, 53: 201-211. 10.1016/0166-6851(92)90022-C.
Sambrook JF, Russell DW: Molecular Cloning, A Laboratory Manual. 2001, New York: Cold Spring Harbor Laboratory, 3
Thomas MC, Longobardo MV, Carmelo E, Maranon C, Planelles L, Patarroyo ME, Alonso C, Lopez MC: Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin Exp Immunol. 2001, 123: 465-471. 10.1046/j.1365-2249.2001.01478.x.
Planelles L, Thomas M, Pulgar M, Marañón C, Grabbe S, López MC: Trypanosoma cruzi heat-shock protein-70 kDa, alone or fused to the parasite KMP11 antigen, induces functional maturation of murine dendritic cells. Immunol Cell Biol. 2002, 80: 241-247. 10.1046/j.1440-1711.2002.01081.x.
Cuellar A, Santander SP, Thomas MC, Guzmán F, Gómez A, López MC, Puerta CJ: Monocyte-derived dendritic cells from chagasic patients vs healthy donors secrete differential levels of IL-10 and IL-12 when stimulated with a protein fragment of Trypanosoma cruzi heat-shock protein-70. Immunol Cell Biol. 2008, 86: 255-260. 10.1038/sj.icb.7100146.
Steindel M, Pacheco LK, Scholl D, Soares M, de Moraes MH, Kosmann C, Sincero TC, Stoco PH, Murta SMF, Carvalho-Pinto CJ, Grisard EC: Characterization of Trypanosoma cruzi isolated from humans and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina, Brazil. Diagn Microbiol Infect Dis. 2008, 60: 25-32.
Beltrán M, Duque S, Guhl F, Herrera CP, López MC, Moreno AL, Nicholls RS, Santacruz MM: Prueba de ELISA y prueba de inmunofluorescencia indirecta (IFI). Manual de procedimientos para el diagnóstico de la enfermedad de Chagas. Edited by: Guhl F, Nicholls RS. 2001, Bogotá:Ministerio de Salud, 32-48.
Milei J, Guerri-Guttenberg RA, Grana DR, Storino R: Prognostic impact of Chagas disease in the United States. Am Heart J. 2009, 157: 22-29. 10.1016/j.ahj.2008.08.024.
Llewellyn MS, Miles MA, Carrasco HJ, Lewis MD, Yeo M, Vargas J, Torrico F, Diosque P, Valente V, Valente SA, Gaunt MW: Genome-scale multilocus microsatellite typing of Trypanosoma cruzi discrete typing unit I reveals phylogeographic structure and specific genotypes linked to human infection. PLoS Pathog. 2009, 5: e1000410-10.1371/journal.ppat.1000410.
Krettli AU, Brener Z: Protective effects of specific antibodies in Trypanosoma cruzi infections. J Immunol. 1976, 116: 755-760.
Franchin G, Pereira-Chioccola VL, Schenkman S, Rodrigues MM: Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in mice. Infect Immun. 1997, 65: 2548-2554.
Díez H, Guzmán F, Alba MP, Cuéllar A, Thomas MC, López MC, Rosas F, Velasco V, González JM, Patarroyo ME, Puerta CJ: Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein. Peptides. 2007, 28: 1520-1526. 10.1016/j.peptides.2007.06.017.
Umezawa ES, Nascimento MS, Kesper N, Coura JR, Borges-Pereira J, Junqueira AC, Camargo ME: Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. J Clin Microbiol. 1996, 34: 2143-2147.
Takehara HA, Da Silva AM, Brodskyn CI, Mota I: A comparative study of anti-Trypanosoma cruzi serum obtained in acute and chronic phase of infection in mice. Immunol Lett. 1989, 23: 81-85. 10.1016/0165-2478(89)90117-X.
Mejía-Jaramillo AM, Peña VH, Triana-Chávez O: Trypanosma cruzi: biological characterization of lineages I and II supports the predominance of lineage I en Colombia. Exp Parasitol. 2009, 121: 83-91. 10.1016/j.exppara.2008.10.002.
dos Santos DM, Talvani A, Guedes PM, Machado-Coelho GL, de Lana M, Bahia MT: Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection. Exp Parasitol. 2009, 121: 8-14. 10.1016/j.exppara.2008.09.012.
Requena JM, Soto M, Guzman F, Maekelt A, Noya O, Patarroyo ME, Alonso C: Mapping of antigenic determinants of the T. cruzi hsp70 in chagasic and healthy individuals. Mol Immunol. 1993, 30: 1115-1121. 10.1016/0161-5890(93)90158-8.
Rico AL, Gironès N, Fresno M, Alonso C, Requena JM: The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones. 2002, 7: 339-346. 10.1379/1466-1268(2002)007<0339:THSPHA>2.0.CO;2.
de Moraes MH, Guarneri AA, Girardi FP, Rodrigues JB, Eger I, Tyler KM, Steindel M, Grisard EC: Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera. Parasit Vectors. 2008, 1: 20-10.1186/1756-3305-1-20.
Cerban FM, Gea S, Menso E, Vottero-Cima E: Chagas' disease: IgG isotypes against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage. Clin Immunol Immunopatho. 1993, 67: 25-30. 10.1006/clin.1993.1041.
Morgan J, Pinto JC, Dias E, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, Powell MR: Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg. 1996, 55: 355-359.
Hernández-Becerril N, Nava A, Reyes PA, Monteón VM: IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Arch Cardiol Mex. 2001, 71: 199-205.
Trujillo C, Ramírez R, Vélez ID, Berberich C: The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas diseaseChagas' disease: prevalence of IgG subclasses and mapping of epitopes. Immunol Lett. 1999, 70: 203-209. 10.1016/S0165-2478(99)00146-7.
Solana ME, Katzin AM, Umezawa ES, Miatello CS: High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease. J Clin Microbiol. 1995, 33: 1456-1460.
Verçosa AF, Lorena VM, Carvalho CL, Melo MF, Cavalcanti MG, Silva ED, Ferreira AG, Pereira VR, Souza WV, Gomes YM: Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients. J Clin Lab Anal. 2007, 21: 271-276. 10.1002/jcla.20186.
Spiegelberg HL: Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol. 1974, 19: 259-294. full_text.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/9/186/prepub